

| Dosage | Package | Price per Dose | Price | |
|---|---|---|---|---|
| 200mg | 360 pills | £0.37 | £178.67 £134.00 Best Price | |
| 200mg | 270 pills | £0.41 | £145.64 £109.23 | |
| 200mg | 180 pills | £0.44 | £105.09 £78.82 | |
| 200mg | 120 pills | £0.47 | £75.06 £56.30 | |
| 200mg | 90 pills | £0.48 | £58.55 £43.91 | |
| 200mg | 60 pills | £0.45 | £36.02 £27.02 | |
| 200mg | 30 pills | £0.51 | £21.01 £15.76 | |
| 400mg | 360 pills | £0.54 | £259.75 £194.82 | |
| 400mg | 180 pills | £0.62 | £148.64 £111.48 | |
| 400mg | 120 pills | £0.70 | £111.10 £83.33 | |
| 400mg | 90 pills | £0.77 | £91.58 £68.69 | |
| 400mg | 60 pills | £0.78 | £61.55 £46.16 | |
| 400mg | 30 pills | £0.95 | £37.52 £28.14 | |
| 600mg | 360 pills | £0.73 | £351.35 £263.51 | |
| 600mg | 270 pills | £0.78 | £279.27 £209.46 | |
| 600mg | 180 pills | £0.83 | £199.69 £149.77 | |
| 600mg | 120 pills | £0.91 | £145.64 £109.23 | |
| 600mg | 90 pills | £0.93 | £112.60 £84.45 | |
| 600mg | 60 pills | £0.96 | £76.56 £57.42 | |
| 600mg | 30 pills | £1.05 | £42.03 £31.52 | |
| 800mg | 360 pills | £0.87 | £415.92 £311.94 Popular | |
| 800mg | 180 pills | £1.02 | £246.24 £184.68 | |
| 800mg | 120 pills | £1.14 | £181.67 £136.26 | |
| 800mg | 90 pills | £1.27 | £153.14 £114.86 | |
| 800mg | 60 pills | £1.39 | £111.10 £83.33 | |
| 800mg | 30 pills | £1.50 | £60.05 £45.04 |
Could Ethambutol Hydrochloride help treat a tuberculosis infection? In many cases, yes. Ethambutol hydrochloride is a first‑line antitubercular agent used in combination regimens to suppress Mycobacterium tuberculosis and prevent resistance. It is administered orally and requires concurrent use with other anti‑tubercular drugs as part of a structured treatment plan.
Chemically, Ethambutol hydrochloride inhibits arabinosyl transferases that assemble the mycobacterial cell wall. The effect is primarily bacteriostatic, slowing bacterial growth while other drugs contribute to killing or containment of the organism. Pharmacokinetic properties include adequate systemic absorption and distribution, with renal elimination playing a major role in clearance. Dose adjustments may be necessary in patients with impaired renal function.
Ethambutol hydrochloride is indicated for active tuberculosis, including pulmonary and certain extrapulmonary forms, when used as part of a multidrug regimen. It may also be employed in select instances of Mycobacterium avium complex infection, particularly where disease warrants combination therapy. It is not used as monotherapy or for latent tuberculosis infection.
Its use centers on resistance prevention and treatment efficacy when paired with other agents such as isoniazid, rifampin, and pyrazinamide. Treatment plans depend on disease extent, patient immune status, and renal function, with regular clinical and laboratory monitoring. Visual monitoring is emphasized due to the risk of optic toxicity associated with ethambutol therapy.
Therapy should follow the prescribing clinician’s schedule. Take Ethambutol hydrochloride at approximately the same time each day to maintain stable drug levels. It can be taken with or without food, although taking it with a meal may lessen potential stomach upset in some patients. Swallow tablets whole with a full glass of water; do not crush or chew sustained‑release forms if present.
If a dose is missed, take it as soon as you remember unless the next dose is due soon. If it is nearly time for the next dose, skip the missed dose and resume the usual schedule. Do not double up doses to catch up, as this can raise the risk of adverse effects. Store at room temperature, away from moisture, heat, and direct light. Keep out of reach of children. Do not use outdated medication or medications from an inappropriately stored supply. If supply issues arise, consult the prescribing clinician rather than altering the regimen on your own.
Common, non‑serious effects include fatigue, nausea, loss of appetite, and mild headaches. Eye symptoms deserve special attention: blurred vision, difficulty distinguishing colors, or any change in central or peripheral vision should prompt prompt medical evaluation. These changes may be reversible if detected early and managed appropriately.
Less common effects include skin rash, fever, or joint discomfort. Rare events involve liver or kidney injury, allergic reactions, or other systemic symptoms. Seek medical advice if you notice dark urine, pale stools, yellowing of the skin or eyes, persistent vomiting, severe abdominal pain, or a widespread rash. Regular follow‑up and eye examinations are often recommended during therapy to detect toxicity early.
Consult a clinician promptly if you experience any new or worsening vision changes, persistent or severe side effects, or signs suggestive of organ injury. Do not discontinue therapy without guidance, as abrupt cessation can compromise treatment efficacy and safety. Seek urgent care for severe allergic reactions or signs of multi‑system involvement.
Before starting Ethambutol hydrochloride, disclose current kidney disease, liver disease, or other major health issues. Provide a full list of medicines, vitamins, and supplements to your clinician to evaluate potential interactions. If pregnancy is planned or suspected, discuss risks and alternatives with a healthcare professional. Ongoing monitoring is essential to balance therapeutic benefit with potential adverse effects.
14–21 days. Free from £150.16 .
5–9 days. £22.52
−10% when paying with cryptocurrency.
−10% on all repeat orders.
All orders are packed in neutral, unbranded boxes with no product name on the outside.
